REPORTREFERENCE OUTLINE

Annual Product Review (APR) Framework

Structured APR/Annual Product Quality Review template aligned to ICH Q10 lifecycle management requirements. Includes data trending sections and CAPA integration fields.

What a template is not

A template is a document baseline to adapt inside your own quality system. SPEQ does not approve, validate, or take responsibility for what you issue from it, and using one is not evidence of compliance.

CHECKING ACCESS

Checking your Professional access…

REGULATIONS MAPPED
ICH Q1021 CFR Part 211
DOCUMENT TYPE
Report
LAST UPDATED
May 2024
PURPOSE

An annual product quality review that consolidates a product's manufacturing and quality data for the review period into a trended assessment — whether the process remained in a state of control, whether the specifications and controls are still appropriate, and what the organisation intends to do about what the data shows. A review that lists events without trending them satisfies the form and misses the purpose.

What's Inside

✓Product and review-period scope, including sites, presentations, and markets covered
✓Batch and yield summary with in-process and finished-product results trended rather than tabulated
✓Deviation, OOS, and complaint trending, grouped by cause so recurrence is visible
✓Change control review — what changed, what it affected, and whether the change did what it was approved to do
✓Stability results against the approved shelf life, including any adverse trend
✓Returns, recalls, and rejections, with the quality signal separated from commercial returns
✓CAPA integration and effectiveness, and conclusions with named continual-improvement actions

How to Use It

1Set the review period and scope first, and keep them consistent year over year so trends are comparable
2Trend the data rather than listing it — a year of deviations sorted by date tells you nothing a log did not
3Group quality events by cause, so a recurring root cause appearing under six event numbers is visible as one problem
4Test the specifications and controls against the period's data, and say plainly where they no longer fit
5Carry every conclusion into a named action with an owner, or state explicitly that no action is required and why
6Sign off through management review, and track the prior year's actions to closure in this year's pack
DOCUMENT CONTENTS

The full section structure of this template — every section and sub-section, so you can use it as a baseline for your own site document.

—Document Control
› Document Information› Approval Signatures› Revision History› Distribution List
1Product and Review-Period Scope
2Batch and Yield Summary
3Deviation, OOS, and Complaint Trending
4Change Control and Stability Review
5Returns, Recalls, and Rejections
6CAPA Integration and Effectiveness
7Conclusions and Continual-Improvement Actions
8Quality Management Review Sign-off
REGULATORY CONTEXT

21 CFR 211.180(e) requires an annual review of records for each drug product to determine whether specifications or procedures need changing, and EU GMP Chapter 1 sets out the Product Quality Review with a broader data set including starting materials, qualification status, and technical agreements. ICH Q10 places both inside the pharmaceutical quality system as inputs to management review and continual improvement. The trend-first structure here is SPEQ synthesis; the conclusions and the actions are the organisation's determination.

MAPPED STANDARDS
ICH Q1021 CFR Part 211
Browse the standards catalog →